Headline News about Bristol-Myers Squibb
![](https://www.investors.com/wp-content/uploads/2017/11/stock-Salesforce-03-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/18/screenshot_2022-10-18_at_6.05.47_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2015/07/10/20/54/stethoscope-840125_960_720.jpg)
![](https://g.foolcdn.com/editorial/images/704362/invitae.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19088.jpeg?width=1200&height=800&fit=crop)
![](https://fastgraphs.com/wp-content/uploads/2022/10/BMY-1024x603.png)
![](https://cdn.benzinga.com/files/images/story/2022/09/19/aapharma_3.png?width=1200&height=800&fit=crop)
Bristol Myers' Opdivo Combo Treatment Scores European Approval For Skin Cancer Setting
September 19, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/704128/a-couple-smiling-and-talking-with-an-advisor.jpg)
![](https://investorplace.com/wp-content/uploads/2021/09/undervalued-stocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5312.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_27878.jpeg?width=1200&height=800&fit=crop)
Will Chart Analysts Notice Bad Omen on Bristol-Myers Squibb's Chart
October 10, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5266.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
October 10, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/702663/three-scientists.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/07/aapharma_5.png?width=1200&height=800&fit=crop)
PureTech Health Confirms 'Possible' Merger With Nektar Therapeutics
October 07, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/06/screenshot_2022-10-06_at_6.15.15_pm.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/703360/pharmacist_xeeHST2.jpeg)
![](https://investorplace.com/wp-content/uploads/2021/12/10beststocks2022-1.jpg)
![](https://investorplace.com/wp-content/uploads/2021/12/10beststocks2022-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/04/aapharma_4.png?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/28/aapharma_17.png?width=1200&height=800&fit=crop)
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/23/image39_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/23/stock-exchange-g894ab76ae_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/22/dices-over-newspaper-2656028_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/22/aapharma_2.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/nktx_cancerresearch1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17273.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/19/image-amazon-3.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/03/penny-stocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/19/image21.jpg?width=1200&height=800&fit=crop)
US Stock Futures Down Ahead Of Fed's Rate Decision This Week, Crude Oil Drops Over 1%
September 19, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.